Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 13, 2019 at 02:32 pm
Share
Easywell Biomedicals, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 107.537 million compared to TWD 83.758 million a year ago. Operating loss was TWD 57.817 million compared to TWD 58.783 million a year ago. Net loss was TWD 66.334 million compared to TWD 62.532 million a year ago. Basic loss per share from continuing operations was TWD 0.54 compared to TWD 0.56 a year ago. Basic loss per share was TWD 0.61 compared to TWD 0.63 a year ago. For the half year, sales was TWD 191.261 million compared to TWD 175.954 million a year ago. Operating loss was TWD 112.069 million compared to TWD 110.417 million a year ago. Net loss was TWD 128.890 million compared to TWD 116.305 million a year ago. Basic loss per share from continuing operations was TWD 1.07 compared to TWD 1.06 a year ago. Basic loss per share was TWD 1.21 compared to TWD 1.18 a year ago.
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.
EASYWELL BIOMEDICALS, INC. 
